Thomas D. Stanton
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- Antibiotic Resistance in Bacteria 7
-
- Escherichia coli research studies 4
- Enterobacteriaceae and Cronobacter Research 1
- Co-authors
- Kelly L. Wyres (6 shared papers)Kathryn E. Holt (4 shared papers)Louise M. Judd (2 shared papers)Ryan R. Wick (2 shared papers)Sophia David (1 shared paper)Margaret M. C. Lam (1 shared paper)Kara K. Tsang (1 shared paper)Iren Høyland Löhr (1 shared paper)
- Journals
- Microbial Genomics (2 papers)mSystems (1 paper)Emerging Microbes & Infections (1 paper)iScience (1 paper)PLoS Medicine (1 paper)
- Partner nations
- AustraliaUnited KingdomSingapore
In The Last Decade
Thomas D. Stanton
10 papers receiving 738 citations
Thomas D. Stanton's Hit Papers
Peers
Comparison fields: 5 of 71
- Infectious Diseases 515
- Modeling and Simulation 88
- Molecular Medicine 43
- Endocrinology 18
- Clinical Biochemistry 9
Countries citing papers authored by Thomas D. Stanton
This map shows the geographic impact of Thomas D. Stanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Stanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Stanton more than expected).
Fields of papers citing papers by Thomas D. Stanton
This network shows the impact of papers produced by Thomas D. Stanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Stanton. The network helps show where Thomas D. Stanton may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas D. Stanton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study Hit paper breakdown → | 2021 | 592 |
| 2 | 2021 | 68 | |
| 3 | 2023 | 41 | |
| 4 | 2024 | 13 | |
| 5 | 2025 | 13 | |
| 6 | 2025 | 10 | |
| 7 | 2025 | 7 | |
| 8 | 2025 | 6 | |
| 9 | 2025 | 4 | |
| 10 | 2026 | 1 |
About Thomas D. Stanton
Thomas D. Stanton is a scholar working on Molecular Medicine, Endocrinology, Microbiology, Infectious Diseases and Clinical Biochemistry, having authored 10 papers that have together received 755 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Escherichia coli research studies (4 papers), Genomics and Phylogenetic Studies (3 papers), Bacterial Infections and Vaccines (2 papers), Neonatal and Maternal Infections (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Enterobacteriaceae and Cronobacter Research (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Infectious Diseases (515 citations), Modeling and Simulation (88 citations), Molecular Medicine (43 citations), Endocrinology (18 citations) and Clinical Biochemistry (9 citations). Thomas D. Stanton has collaborated with scholars based in Australia, United Kingdom and Singapore. Frequent co-authors include Kelly L. Wyres, Kathryn E. Holt, Louise M. Judd, Ryan R. Wick, Sophia David, Margaret M. C. Lam, Kara K. Tsang, Iren Høyland Löhr, David M. Aanensen and Sylvain Brisse. Their work appears in journals such as Microbial Genomics, mSystems, Emerging Microbes & Infections, iScience and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.